Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025

Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025#Fractyl #Health #Unveils #Rejuva #Smart #GLP1 #Pancreatic #Gene #Therapy #Preclinical #Data #Highlighting #Durable #Potency #Safety #Limited #Systemic #GLP1 #Exposure #ASGCT